3,3',4,4',5-Pentachloro-1,1'-biphenyl; 3,3',4,4',5-Pentachlorobiphenyl; 3,4,3',4',5'-Pentachlorobiphenyl; 3,4,5,3',4'-Penta coplanar polychlorinated biphenyl; PCB 126; 1,1'-Biphenyl, 3,3',4,4',5-pentachloro-; [ChemIDplus] UN3432
White solid; [Cerilliant MSDS]
Clear evidence of carcinogenicity in female rats; [NTP] Classified as Group 1 based on animal evidence and mechanistic data (strong evidence for an aryl hydrocarbon receptor) without epidemiological evidence; [IARC 2012] May have cumulative adverse effects; Targets the liver, kidney, CNS, and skin; [Cerilliant MSDS] See "Polychlorinated biphenyls" and linked occupational disease.
Hepatoxic (a) from occupational exposure (secondary effect) or (b) in animal studies or in humans after ingestion
Occupational diseases associated with exposure to this agent: